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RABBIT SYNDROME :AN UNCOMMON SIDE EFFECT OF NEUROLEPTICS 
MANILAL GADA 
ABSTRACT 
The rabbit syndrome, a neuroleptic induced extrapyramidal side effect with Vafe onset, 
consists of rapid fine rhythmic movements of the lips that mimic the chewing movements of a 
rabbit. This syndrome was first described by Villeneuve in 1972. Unlike the buccolingual 
movements of the tardive dyskinesia, the rabbit syndrome improves with antiparkinsonian 
medication. The condition is reported to be rare. To the best knowledge of the author, no case has 
been described or reported from India. A case of rabbit syndrome is described with review of the 
literature. 
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Rabbit syndrome is a perioral involuntary, 
extrapyramidal movement distrubance associ-
ated with prolong use of neuroleptics 
(Villeneure, 1972; Berger and Roxroth, 1980). 
The distrubance involves the oral and 
masticatory musculature except for the tongue; 
it is similar in appearance to the movements of 
rabbit's mouth. Quickly alternating, regular 
movements along a vertical axis occur at 
frequency of approximately 5 Hz. There is an 
associated popping like sound produced as the 
lips rapidly separate. Differential diagnosis 
between tardive dyskinesia and rabbit syndrome 
is often confused; tardive dyskinesis also can 
invlove orofacial musculature but is manifested 
by chewing like movements that include 
writhing or thrusting tongue motion. Differen-
tiation between the two conditions is made 
clinically. Abnormal movements in tardive 
dyskinesia are significantly slower and less 
regular than in rabbit syndrome. Although both 
disorders are sequelae of long-term neurolep-
tic treatment (Jus etal., 1979), rabbit syndrome 
responds to antiparkinsonian medication, while 
tardive dyskinesia is often exacerbated by such 
therapy. 
Rabbit syndrome was first described by 
Villeneuve in 1972. The condition is reported 
to be rare (Todd et al., 1S83). 
To the best of author's knowledge no such 
case is reported or published from India. A case 
of rabbit syndrome is described. 
CASE REPORT 
Ms A, 46 years old medical graduate, 
had undergone treatment for psychosis from 
psychiatrists. She was hospitalised several 
times. Results of physical examination 
and CT scan were normal. She was 
diagnosed to be suffering from chronic 
schizophrenia with acute exacerbations off and 
on. She was on oral flupenthixol for last one 
year without any antiparkinsonian medication. 
Earlier she was given other neuroleptics like 
haloperidol, trifluoperazine etc. 
She was noticed to have rapid 
involuntary orofacial movements without lingual 
involvement. Her jaw moved alternately up and 
down. The movements decreased in severity 
with voluntary activity including talking. No other 
extrapyramidal signs were present. A 
diagnosis of rabbit syndrome was made. Oral 
flupenthixol was stopped and trihexyphendyl 
HCI2 mg three times a day was started. Within 
4 days, she responded to the treatment and in 
a fortnight, all the movements stopped. 
Flupenthixol was reintroduced later along 
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with trihexyphenydil HCI.No abnormal 
movements were noticed later. 
DISCUSSION 
The rabbit syndrome has been reported 
primarily in middle-aged and elderly patients 
(Jus et al., 1979). It occurs with a variety of 
neuroleptics. Following neuroleptics have been 
reported to produce rabbit syndrome-haloperi-
dol, fluphenazine, perphenezine, trifluopera-
zine, thioproperazine and mesoridazine (Sovner 
and Mascio, 1977; Todd et al., 1983; Yassa and 
Lai, 1986). 
Anticholinergic agents in general 
aggravate or uncover tardive dyskinesia, 
although in some cases no effect or 
occasionally amelioration occurs (Gerlach et al., 
1974). In contrast, anticholinergics consistently 
improve the rabbit syndrome, as was noted in 
the present case. 
The rabbit syndrome is uncommon in 
patients chronically treated with neuroleptics. 
Yassa and Lai (1986) reported the incidence to 
be 2.3%. The reasons for the apparent 
infrequency of rabbit syndrome may be related 
to the following factors: (1) many patients 
receive concomitant antiparkinsonian medica-
tion; (2) it is not a well-known side effect and 
may be mistaken for tardive dyskinesia; (3) in 
some patients the syndrome is mild and only 
elicited by a distracting task and (4) most scales 
used to evaluate extrapyramidal symptoms do 
not include an item for the rabbit syndrome (an 
exception is the Simpson Rating Scale for Tar-
dive Dyskinesia). Failure to recognise the 
rabbit syndrome and concern over aggravating 
tardive dyskinesia may lead to withholding higly 
effective treatment with anticholinergic agents 
or unecessarily reducing the dose of required 
neuroleptic. 
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